Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Roald Dahl
This qualitative investigation explores the medication experience and factors influencing adherence to oral targeted therapy among lung cancer survivors. Through individual interviews and focus group discussions, lung cancer survivors prescribed oral targeted therapy were asked about their experiences and the factors impacting their adherence. Thematic analysis was used to identify recurring themes and patterns in the data. The findings shed light on participants’ perspectives on the medication, including perceptions of benefits and risks, experiences with side effects, and interactions with healthcare providers. Factors influencing adherence, such as financial constraints, medication reminders, social support, and information provided by healthcare professionals, were also identified. The insights gained from this study can inform healthcare providers in developing strategies to support patients in effectively adhering to oral targeted therapies. Interventions, educational programs, and supportive care services can be tailored to address the identified challenges and improve medication adherence among lung cancer survivors.